Dokumente im Korb
Helmholtz Zentrum München
|
Imprint
PuSH - Publication Server of Helmholtz Zentrum München
OA Journals
|
Where to Publish?
|
Where not to Publish
|
Information
Clues to quality of journals
Open Access Policy of Helmholtz Association 2016
CC Licencences
Publication Metrics
Navigation
Home
Deutsch
EVA: Electronic Publishing
New EVA Application
Research
Advanced Search
Browse by ...
... HMGU-Authors/Consortia
... Organizational Structure
... Journal
... Publication Type
... Research Data
... Arbeitsgruppen
... Publication Year
Publication overview
Statistics
Statistics (last 5 years)
OA Publications
Publish
Submit Publication
Import publication from...
...EVA
Antragsnummer or
EVA-ID:
Report missing publication
Highlights
Search
Support & Contact
Contact persons
Help
Data protection
Helmholtz Open Science
JANE Journal Estimator
SHERPA/RoMEO
DOAJ
Export:
Text
Endnote (RIS)
BibTeX
Bhonde, M.R.* ; Hanski, M.L.* ;
Budczies, J.
; Cao, M.* ; Gillissen, B.* ; Moorthy, D.* ; Simonetta, F.* ; Scherübl, H.* ; Truss, M.* ; Hagemeier, C.* ;
Mewes, H.-W.
; Daniel, P.T.* ; Zeitz, M.* ; Hanski, C.*
DNA damage-induced expression of p53 suppresses mitotic checkpoint kinase hMps1.
J. Biol. Chem.
281
, 8675-8685 (2006)
Publ. Version/Full Text
Research data
DOI
Open Access Gold
as soon as is submitted to ZB.
Abstract
Metrics
Extra information
DNA damage induced by the topoisomerase I inhibitor irinotecan (CPT-11) triggers in p53WT colorectal carcinoma cells a long term cell cycle arrest and in p53MUT cells a transient arrest followed by apoptosis (Magrini, R., Bhonde, M. R., Hanski, M. L., Notter, M., Scherübl, H., Boland, C. R., Zeitz, M., and Hanski, C. (2002) Int. J. Cancer 101, 23-31; Bhonde, M. R., Hanski, M. L., Notter, M., Gillissen, B. F., Daniel, P. T., Zeitz, M., and Hanski, C. (2006) Oncogene 25, 165-175). The mechanism of the p53-independent apoptosis still remains largely unclear. Here we used five p53WT and five p53MUT established colon carcinoma cell lines to identify gene expression alterations associated with apoptosis in p53MUT cells after treatment with SN-38, the irinotecan metabolite. After treatment, 16 mitosis-related genes were found to be expressed at least 2-fold stronger in the apoptosis-executing p53MUT cells than in the cell cycle-arrested p53WT cells by oligonucleotide microarray analysis. One of the genes whose strong post-treatment expression was associated with apoptosis was the mitotic checkpoint kinase hMps1 (human ortholog of the yeast monopolar spindle 1 kinase). hMps1 mRNA and protein expression were suppressed by the treatment-induced and by the exogenous adenovirus-coded p53 protein. The direct suppression of hMps1 on RNA level or inhibition of its activity by a dominant-negative hMps1 partly suppressed apoptosis. Together, these data indicate that the high expression of mitotic genes in p53 MUT cells after SN-38 treatment contributes to DNA damage-induced apoptosis, whereas their suppression in p53WT cells acts as a safeguard mechanism preventing mitosis initiation and the subsequent apoptosis. hMps1 kinase is one of the mitotic checkpoint proteins whose expression after DNA damage in p53 MUT cells activates the checkpoint and contributes to apoptosis. © 2006 by The American Society for Biochemistry and Molecular Biology, Inc.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
5.854
1.219
32
35
Tags
Annotations
Special Publikation
Hide on homepage
Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Keywords plus
Language
english
Publication Year
2006
Prepublished in Year
HGF-reported in Year
0
ISSN (print) / ISBN
0021-9258
e-ISSN
1083-351X
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Journal
Journal of Biological Chemistry, The
Quellenangaben
Volume: 281,
Issue: 13,
Pages: 8675-8685
Article Number: ,
Supplement: ,
Series
Publisher
American Society for Biochemistry and Molecular Biology
Publishing Place
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application number
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
Institute(s)
Institute of Bioinformatics and Systems Biology (IBIS)
POF-Topic(s)
30505 - New Technologies for Biomedical Discoveries
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-503700-001
Grants
Copyright
DOI
10.1074/jbc.M511333200
Scopus ID
33646843583
Erfassungsdatum
2006-11-07
[➜Report correction]